KR840006627A - Method for preparing benzazine derivatives - Google Patents

Method for preparing benzazine derivatives Download PDF

Info

Publication number
KR840006627A
KR840006627A KR1019830005432A KR830005432A KR840006627A KR 840006627 A KR840006627 A KR 840006627A KR 1019830005432 A KR1019830005432 A KR 1019830005432A KR 830005432 A KR830005432 A KR 830005432A KR 840006627 A KR840006627 A KR 840006627A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
reaction
alkyl
general formula
Prior art date
Application number
KR1019830005432A
Other languages
Korean (ko)
Other versions
KR900006325B1 (en
Inventor
라이펜 맨프레드
Original Assignee
베첼, 좀머
닥터 칼 토메 게젤샤프트 미트 베쉬랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베첼, 좀머, 닥터 칼 토메 게젤샤프트 미트 베쉬랭크터 하프퉁 filed Critical 베첼, 좀머
Publication of KR840006627A publication Critical patent/KR840006627A/en
Application granted granted Critical
Publication of KR900006325B1 publication Critical patent/KR900006325B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음.No content.

Description

벤즈아제핀 유도체의 제조방법Method for preparing benzazine derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (10)

a)일반식(II)의 벤즈아제핀을 용매중에서 루테늄 테트록사이드로 산화시키거나, (b) 일반식(III)화합물을 폐환시키고 경우에 따라, 수득된 일반식(I)화합물을 그의 산부가염 특히, 그의 무기 또는 유기산과의 생리학적으로 적절한 산부가염으로 전환시킴을 특징으로 하여 일반식(I)의 벤즈아제핀유도체 및 그의 산부가염 특히 그의 무기 또는 유기산과의 생리학적으로 적절한 산부가염을 제조하는 방법.a) oxidizing the benzazine of general formula (II) to ruthenium tetroxide in a solvent, or (b) closing the compound of general formula (III) and optionally converting the compound of general formula (I) Salts, in particular the conversion of physiologically suitable acid addition salts with inorganic or organic acids thereof, to benzazine derivatives of general formula (I) and acid addition salts thereof, in particular How to make. 상기식에서, E는 에틸렌, n-프로필렌 또는 n-부틸렌그룹 (탄소수 1내지 3의 알킬그룹에 의해 임의로 치환된)을 나타내며; G는 메틸렌 또는 에틸렌그룹(탄소수 1내지 3의 알킬그룹에 의해 임의로 치환된)을 나타내고; R1및 R2는 등일하거나 다를 수 있으며, 하드록시 그룹, 알킬, 알콕시 또는 페닐알콕시그룹(각각의 경우에 알킬 부분은 탄소수 1내지 3을 함유할 수 있다)을 나타내거나, R1또는 R2중의 하나는 또한 수소원자를 나나타내거나, R1및 R2는 함께 탄소수 1내지 2의 알킬렌디옥시 그룹을 나타내며; R3및 R4는 등일하거나 다를 수 있으며, 수소 또는 할로겐원자, 하이드록시그룹, 탄소수 1내지 R4의 알킬 또는 알콕시그룹 또는 트리플루오로메틸 또는 시아노그룹을 나태내거나 R3또는 R4중의 하나는 니트로그룹을 나타내거나 R3및 R4는 함께 탄소수 1 내지 2의 알킬렌디옥시 그룹을 나타내고 R5는 수소원자, 하이드록시 또는 아미노그룹, 알킬, 알콕시, 알킬아미노, 디알킬 아미노, 알카노일아미노, 알콕시 카보닐아미노 또는 비스(알콕시카보닐) 아미노그룹(각각의 경우에 알킬부위는 탄소수 1내지 3을 함유할 수 있다)또는 트리플루오로메틸 그룹으로 치환된 메틸아미노 또는 에틸아미노 그룹을 나타내며; R6는 수소원자, 알킬, 페닐알킬, 알카노일 또는 알콕시카보닐그룹(각각의 경우 알킬부분은 탄소수 1 내지 3을 함유할 수 있다) 또는 탄소수 3내지 5의 알케닐 그룹을 나타내고; R6'는 아미노그룹의 보호그룹을 나타내거나 전술된 R6를 나타내며; X는 폐환에 적절한 그룹을 나타낸다.Wherein E represents an ethylene, n-propylene or n-butylene group (optionally substituted by alkyl groups of 1 to 3 carbon atoms); G represents methylene or ethylene group (optionally substituted by an alkyl group having 1 to 3 carbon atoms); R 1 and R 2 may be equivalent or different and represent a hydroxy group, alkyl, alkoxy or phenylalkoxy group (in each case the alkyl moiety may contain 1 to 3 carbon atoms), or R 1 or R 2 One of which also represents a hydrogen atom, or R 1 and R 2 together represent an alkylenedioxy group having 1 to 2 carbon atoms; R 3 and R 4 may be the same or different and represent hydrogen or a halogen atom, a hydroxy group, an alkyl or alkoxy group having 1 to R 4 carbon atoms or a trifluoromethyl or cyano group or one of R 3 or R 4 Represents a nitro group or R 3 and R 4 together represent an alkylenedioxy group having 1 to 2 carbon atoms and R 5 represents a hydrogen atom, a hydroxy or amino group, alkyl, alkoxy, alkylamino, dialkyl amino, alkanoylamino Alkoxy carbonylamino or bis (alkoxycarbonyl) amino group (in each case the alkyl moiety may contain from 1 to 3 carbon atoms) or methylamino or ethylamino group substituted with trifluoromethyl group; R 6 represents a hydrogen atom, alkyl, phenylalkyl, alkanoyl or alkoxycarbonyl group (in each case the alkyl moiety may contain 1 to 3 carbon atoms) or an alkenyl group of 3 to 5 carbon atoms; R 6 ′ represents a protecting group of an amino group or R 6 described above; X represents a group suitable for ring closure. 제1항의 a)에 있어서, 산화에 사용된 루테늄 테트록사이드가 반응혼합물내에서 제조되는 방법.The process of claim 1, wherein the ruthenium tetroxide used for oxidation is prepared in the reaction mixture. 제1항의 a)또는 2항에 있어서, 산화반응이 0내지 100℃, 바람직하게는 20내지 50℃의 온도에서 수행되는 방법.The process according to claim 1 a) or 2, wherein the oxidation reaction is carried out at a temperature between 0 and 100 ° C, preferably between 20 and 50 ° C. 제1항의 b)에 있어서, 반응이 100내지 250℃에서 바람직하겐느 140내지 180℃에서 수행되는 방법.The process according to claim 1, wherein the reaction is carried out at 100 to 250 ° C, preferably at 140 to 180 ° C. 제1항의 b) 또는 4항에 있어서, 반응이 용매중에 수행되는 방법.The process of claim 1 b) or 4, wherein the reaction is carried out in a solvent. 제1항의 b), 4항 또는 5항에 있어서, 반응이 축합제 존재하에 수행되는 방법.The process of claim 1 b), 4 or 5, wherein the reaction is carried out in the presence of a condensing agent. 제1항의 b) 또는 4내지 6항중 어느 하나에 있어서, OH 및 NH2그룹이 존재할 경우 이는 반응하는 동안 보호되고, 반응 후에 제거되는 방법.Process according to claim 1 b) or 4 to 6, wherein OH and NH 2 groups, when present, are protected during the reaction and removed after the reaction. 제6항에 있어서, N,N′-디사이클로-헥실카보디이미드 또는 티오닐클로라이드, 포스포네이트, 포스포란 또는 N-알킬-피리디늄염, N,N′-디사이클로헥실 카보디이미드/4-디메틸아미노피리딘, 클로로술 포닐 이소시아네이트, 또는 R6가 수소원자가 아닌 경우에는 N,N′-카보닐디이미다졸도 또한 축합제로 사용되는 방법.7. N, N'-dicyclo-hexylcarbodiimide or thionylchloride, phosphonate, phosphoran or N-alkyl-pyridinium salt, N, N'-dicyclohexyl carbodiimide / N, N'-carbonyldiimidazole is also used as a condensing agent when 4-dimethylaminopyridine, chlorosulfonyl isocyanate, or R 6 is not a hydrogen atom. 제7항에 있어서, 보호그룹으로서 아실그룹이 사용되고, 이 그룹은 반응후에 가수분해에 의해 제거되는 방법.8. The method of claim 7, wherein an acyl group is used as a protecting group, which group is removed by hydrolysis after the reaction. 제7항에 있어서, 보호그룹으로서 벤질그룹이 사용되고, 이 그룹은 반응 후에 수소화에 의해 제거되는 방법.8. A process according to claim 7, wherein a benzyl group is used as the protecting group, which group is removed by hydrogenation after the reaction. ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: It is to be disclosed based on the initial application.
KR1019830005432A 1982-11-16 1983-11-16 Process for preparation of benzazepine derivatives KR900006325B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3242345.4 1982-11-16
DE19823242345 DE3242345A1 (en) 1982-11-16 1982-11-16 Process for the preparation of benzazepine derivatives

Publications (2)

Publication Number Publication Date
KR840006627A true KR840006627A (en) 1984-12-01
KR900006325B1 KR900006325B1 (en) 1990-08-28

Family

ID=6178258

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005432A KR900006325B1 (en) 1982-11-16 1983-11-16 Process for preparation of benzazepine derivatives

Country Status (12)

Country Link
KR (1) KR900006325B1 (en)
AT (1) AT389509B (en)
CA (1) CA1207764A (en)
DD (1) DD215541A5 (en)
DE (1) DE3242345A1 (en)
DK (1) DK155666C (en)
ES (2) ES8502425A1 (en)
FI (1) FI77234C (en)
GR (1) GR79427B (en)
HU (1) HU190918B (en)
NO (1) NO168244C (en)
PT (1) PT77676B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474090A (en) * 1966-12-22 1969-10-21 American Cyanamid Co 3-aminoalkyl-1,3-benzodiazepin-2-ones
US3780023A (en) * 1972-06-30 1973-12-18 J Suh 2-aralkylamino-4,5-dihydro-3h-1,3-benzodiazepines
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
DE2639718A1 (en) * 1976-09-03 1978-03-16 Thomae Gmbh Dr K NEW PHENYLAETHYLAMINE

Also Published As

Publication number Publication date
CA1207764A (en) 1986-07-15
ATA363283A (en) 1989-05-15
NO834176L (en) 1984-05-18
ES527270A0 (en) 1985-01-01
PT77676B (en) 1986-05-12
ES8502425A1 (en) 1985-01-01
AT389509B (en) 1989-12-27
DK519983A (en) 1984-05-17
ES8502975A1 (en) 1985-02-01
DE3242345A1 (en) 1984-05-17
HU190918B (en) 1986-12-28
DK155666B (en) 1989-05-01
DK519983D0 (en) 1983-11-14
ES532551A0 (en) 1985-02-01
FI834121A0 (en) 1983-11-10
GR79427B (en) 1984-10-22
FI834121A (en) 1984-05-17
FI77234B (en) 1988-10-31
DD215541A5 (en) 1984-11-14
NO168244B (en) 1991-10-21
KR900006325B1 (en) 1990-08-28
FI77234C (en) 1989-02-10
DK155666C (en) 1989-09-04
PT77676A (en) 1983-12-01
NO168244C (en) 1992-01-29

Similar Documents

Publication Publication Date Title
US2513346A (en) Process for obtaining organic amino diols
KR950701918A (en) N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-teazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8, Process for Producing N-β-Hydroxyalkyl-Tri-N-Carboxyalkyl-1,4,7,10-Tetraazacyclododecane and N-β-Hydroxyalkyl-Tri-N -Carboxyalkyl-1,4,8,11-Tetraazacyclotetradecane Derivatives and Their Metal Complexes
KR890005141A (en) Process for preparing methylene derivative of androstar-1,4-diene-3,17-dione
KR840000508A (en) Method for preparing 4-anilinopyrimidine derivative
ATE49T1 (en) PRODUCTION OF 1-DESOXY-NOJIRIMYCIN AND N-SUBSTITUTED DERIVATIVES.
KR850008666A (en) Method for preparing substituted bis- (4-aminophenyl) -sulfone
SE7712630L (en) PROCEDURE FOR THE PREPARATION OF O-ALKYLATED HYDROXYLAMINES
KR840006482A (en) Method for preparing [3,4-b] pyridine derivative with dihydropyrazolo
GB962293A (en) New sydnonimines and process for their manufacture
KR840006206A (en) Method for preparing isoquinoline derivative
KR840006627A (en) Method for preparing benzazine derivatives
AR026222A1 (en) COMPOUNDS DERIVED FROM ANTRANILIC ACID
DE2114884A1 (en) Basically substituted derivatives of 1 (2H) -phthalazinone
KR880002889A (en) Dicerenobis Benzoic Acid Amine of Primary Demodulation Cyclic Amines, Methods for the Preparation and Pharmaceutical Compounds
KR840005444A (en) Method for preparing tricyclic compound
KR840005107A (en) Method for preparing pyrimidion and acid addition salts thereof
KR840006238A (en) Method for preparing novel α-aryl-α-pyridylalkanoic acid derivatives
ATE8389T1 (en) AMINO-ALKOXY-PYRAZOLE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM.
MX3341E (en) PROCEDURE FOR THE PREPARATION OF EPOXY-ANDROSTANS
KR900018067A (en) Method for preparing cyclic sulfate
KR970074748A (en) Process for preparing 3-amino substituted crotonate
FI82239C (en) FRAMSTAELLNING AV AMINDERIVAT.
KR930009994A (en) Urea fusion method to synthesize 3-phenoxy-1-azetidinecarboxamide
Baiocchi et al. The Peroxide Induced Reaction of Amines with Carbonyl Sulfide
Ramsey et al. Praseodymium and Neodymium Complexes with 8-Quinolinol-5-Sulfonic Acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030728

Year of fee payment: 14

EXPY Expiration of term